First Time Loading...

Pharmagest Interactive SA
F:PHF

Watchlist Manager
Pharmagest Interactive SA Logo
Pharmagest Interactive SA
F:PHF
Watchlist
Price: 54.5 EUR -2.15% Market Closed
Updated: May 13, 2024
Section:
 

Relative Value

The Relative Value of one PHF stock under the Base Case scenario is 79.12 EUR. Compared to the current market price of 54.5 EUR, Pharmagest Interactive SA is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHF Relative Value
Base Case
79.12 EUR
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.7
P/S
P/S
Price to Sales
3.7
vs History
88
vs Industry
34
Median 3Y
5.6
Median 5Y
5.6
Industry
2.4
Forward
3.3
More Details
17.4
P/E
P/E
Price to Earnings
17.4
vs History
88
vs Industry
32
Median 3Y
25.6
Median 5Y
30.8
Industry
23.9
Forward
16.5
More Details
14.2
P/OCF
P/OCF
Price to OCF
14.2
vs History
87
vs Industry
29
Median 3Y
20.9
Median 5Y
23.4
Industry
15.6
More Details
19.9
P/FCFE
P/FCFE
Price to FCFE
19.9
vs History
85
vs Industry
25
Median 3Y
24.7
Median 5Y
26.5
Industry
22.5
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
92
vs Industry
24
Median 3Y
6.6
Median 5Y
7.2
Industry
2.3
More Details
3.7
EV/S
EV/S
Enterprise Value to Sales
3.7
vs History
88
vs Industry
32
Median 3Y
5.4
Median 5Y
5.5
Industry
2.5
Forward
3.3
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
88
vs Industry
42
Median 3Y
7.9
Median 5Y
8.1
Industry
5.3
More Details
11.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.8
vs History
88
vs Industry
30
Median 3Y
17
Median 5Y
18
Industry
12.9
Forward
10.3
More Details
14.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.7
vs History
88
vs Industry
32
Median 3Y
21.3
Median 5Y
21.6
Industry
17.8
Forward
12.6
More Details
14
EV/OCF
EV/OCF
Enterprise Value to OCF
14
vs History
87
vs Industry
31
Median 3Y
20.4
Median 5Y
22.9
Industry
15.4
More Details
20.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.6
vs History
84
vs Industry
24
Median 3Y
24.7
Median 5Y
34.6
Industry
19.6
More Details
2.5
EV/IC
EV/IC
Enterprise Value to IC
2.5
vs History
92
vs Industry
32
Median 3Y
4.3
Median 5Y
4.6
Industry
2
More Details

Multiples Across Competitors

PHF Competitors Multiples
Pharmagest Interactive SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Pharmagest Interactive SA
F:PHF
819.2m EUR 3.7 17.4 11.8 14.7
US
Veeva Systems Inc
NYSE:VEEV
33B USD 13.9 62.5 62.7 67.5
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.8B AUD 81 169.8 116.8 116.8
JP
M3 Inc
TSE:2413
1.1T JPY 4.7 23.9 12.4 13.9
US
Inspire Medical Systems Inc
NYSE:INSP
4.7B USD 7.3 -306.7 -130.7 -119.4
US
Doximity Inc
NYSE:DOCS
4.3B USD 9.2 31.4 20.9 22.3
SE
Sectra AB
STO:SECT B
45.2B SEK 27.6 106.5 -70.1 -70.1
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
US
Evolent Health Inc
NYSE:EVH
2.7B USD 1.4 -19.3 23.1 245.7
P/E Multiple
Earnings Growth
FR
Pharmagest Interactive SA
F:PHF
Average P/E: 65.5
17.4
18%
US
Veeva Systems Inc
NYSE:VEEV
62.5
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
169.8
119%
JP
M3 Inc
TSE:2413
23.9
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -306.7 N/A
US
Doximity Inc
NYSE:DOCS
31.4
79%
SE
Sectra AB
STO:SECT B
106.5
56%
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -19.3 N/A

See Also

Summary
PHF intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHF stock valuation using valuation multiples.
Wall Street Estimates
PHF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.